pentobarbital will decrease the extent or influence of lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with robust CYP3A4 inducers can lead to reduced serum concentrations and lack of antimalarial efficacyRegardless of the growing variety of states that allow for medical-help-in-dying—gener